arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

CONMED Corp

CNMD
$52.79 ▼ -0.90 (-1.68%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
69 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

CONMED Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.6B
Dividend Yield —
Revenue Growth -0.7% ↘
Op. Margin 11.1% ↗
ROIC 2.7% ↗
FCF / Share $1.56
Trailing P/E 80.0x
Price / Book 1.5x
FCF Yield 3.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$335.56M
↓ -0.7% —
Net Income Profit after all expenses
$19.80M
↑ +592.4% —
Operating Margin Operating profit as % of sales
11.1%
↑ +4.4% 50th
FCF / Share Free cash flow per share
$1.56
↑ +28.1% —
Long-Term Debt Long-term obligations
$794.17M
↓ -1.9% —

Health Breakdown

Profitability ↓
53
Returns ↓
53
Financial Health ↑
67
Cash Quality ↑
92

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
-25.0% YoY
-2.6% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters